Findings from a recent study illustrate why you should be talking with your pregnant patients about their consumption of fatty acids.
Judith M. Orvos, ELS
Release of results from the ARRIVE trial has provided answers to some concerns about 39-week induction while leading to some questions about the participants and the implication of the findings for clinical practice. PLUS: CDC updates on Zika virus. Also: FDA warns about tests for rupture of membranes
To fight the opioid epidemic, ob/gyns, like all physicians, are looking for ways to help prevent substance use disorders and enhanced recovery programs (ERAS) could play a role. PLUS: Are EDs screening adolescents with PID for HIV, syphilis? ALSO: Results of a new retrospective study show that a woman’s race may impact how likely she is to have a myomectomy—and alarmingly, whether the procedure is likely to result in morbidity.
Incidence of acute myocardial infarction (AMI) continues to increase in women during pregnancy and the puerperium. Data from a new study point to underlying factors contributing to that trend. PLUS: Results of a large population-based study of POP procedures provide new insights into what factors other than the material may play a role in the adverse surgical outcomes.
Ob/gyns and other women’s health providers can help save Title X for their patients and their voices need to be heard on Capitol Hill. That was the clear message from speakers at a recent media event in Washington, DC.
The manufacturer of a device for permanent birth control that reportedly causes serious adverse events has decided to cease selling it at the end of the year. PLUS: Does smoking cessation really = weight gain? Also: Is prenatal depression more common today?
Research point to risk as well as benefits of extended adjuvant tamoxifen for ER-positive BCa. PLUS: Should breast cancer screening be risk-based? ALSO: Side effects of cross-sex hormones in transwomen.
A meta-analysis of 140 studies by investigators from the Cochrane Collaboration shows that oxytocin may not be the best choice for prevention of postpartum hemorrhage, despite the current recommendation from the World Health Organization (WHO). PLUS: Commentary on the findings from our Maternal Mortality Series Editor, Carolyn Zelop, MD.
A study by investigators from New England suggests that a mother’s diet during pregnancy and lactation may have an impact on the microbiome in her infant’s gut. PLUS: Are prenatal vitamin D levels tied to adverse pregnancy outcomes? ALSO: Results of a survey-based study of attending surgeons shows that they play a major role in whether women with breast cancer receive genetic testing.
An analysis by Danish investigators published in JAMA shows that taking oral fluconazole during pregnancy is associated with a significant increased risk of spontaneous abortion. Plus: What persuades parents to vaccinate for HPV? Also: Does prenatal exposure to lithium increase risk of congenital malformations?